Jump to navigation
Overlooked by the international community, the already-dire situation in Kenya's overcrowded Dadaab refugee camps is worsening.
In the remote Jebel Si area of North Darfur, a series of obstacles threaten to seriously hamper MSF's ability to provide medical assistance.
MSF is a central player in treating lead poisoning in Zamfara state, and is responding to the acute phase of this emergency.
MSF calls on the stakeholders of the Global Fund to convene an emergency donor conference and to open a new early funding window to ensure that the Fund is fully functional in 2012.
This update details MSF's recent activities in South Sudan, the world's newest nation.
Read MSF's submission to the US trade representative on the 2012 Special 301 review process, which affects accessibility of medicines and important diagnostic tools.
Read Novartis's statements on its generic medicines court case, and learn why they're wrong.
Learn more about why Novartis is taking India to court over the production of affordable generic medicines.
Novartis is taking India to court to stop production of affordable generic medicines that millions of people depend on to stay alive.
Learn how a free trade agreement between the European Union and India could restrict access to affordable medicines for millions of people with HIV/AIDS and other diseases and conditions.
333 7th Avenue, New York, NY 10001-5004
A 501(c)(3) tax-exempt organization. Federal Identification Number (EIN): 13-3433452.